Clinical Trial Update: Development of Multiphasic CT-based Delta-Radiomics Model for Predicting Postoperative Recurrence Risk in Bladder Cancer

View source ↗

Summary

This clinical trial completed development of a multiphasic CT-based delta-radiomics model to predict postoperative recurrence risk in bladder cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Snippet

Sponsor: Lian Yang | Conditions: Bladder Cancer | Status: COMPLETED